Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective

by Daniela Paola Roggeri, Ezio Zanon, Chiara Biasoli, Alessandro Roggeri
Published 2020-06-01

Funding Innovation Thanks to Anti-TNF-α Biosimilars Uptake: The Economic Impact in Italy

by Massimiliano Povero, Lorenzo Pradelli
Published 2020-05-01

Analysis of Market Access Agreements in Turkey

by Guvenc Kockaya, Okan Atalay, Mustafa Kurnaz, Selin Okcun, Nazlı Sencan, Cigdem Gedik, Mete Saylan, Gulpembe Oguzhan
Published 2020-10-01

Real-life Diagnostic and Therapeutic Approach to CLL: A New Proposal from an Expert Panel in Tuscany Region

by Monica Bocchia, Alberto Bosi, Enrico Capochiani, Stefania Ciolli, Romano Danesi, Sara Galimberti, Alessandro Gozzetti, Sabrina Moretti, Ubaldo Occhini, Mario Petrini
Published 2020-02-01

Critical Review of the Pivotal Studies of Four rFVIII Products for the Treatment of Hemophilia A Patients: The Role of Octocog Alfa

by Matteo Nicola Dario Di Minno, Lucia D'Angiolella, Paolo Angelo Cortesi, Angelo Claudio Molinari, Lorenzo Giovanni Mantovani
Published 2020-04-01

Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes

by Edoardo Mannucci, Pier Paolo Mangia, Lorenzo Pradelli
Published 2020-12-01

The Economic Burden of Different Multiple Sclerosis Courses: Analysis from Italian Administrative and Clinical Databases

by Paolo Angelo Cortesi, Paolo Cozzolino, Ruggero Capra, Giancarlo Cesana, Lorenzo Giovanni Mantovani
Published 2020-06-01

Il mercato dei dispositivi per stomia in cinque paesi europei: lezioni per l’Italia

by Dante Cornago, Livio Garattini
Published 2001-06-01

I costi della sepsi in Italia

by C. Lucioni, I. Currado, M. Langer, S. Mazzi
Published 2001-09-01

Costruzione di un modello decisionale per valutare la costo/efficacia delle strategie alternative nella terapia della polmonite acquisita in comunità

by Mario Eandi
Published 2001-03-01

An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West

by Giancarlo Casolo, Giuseppe Cavirani, Alessandro Del Carlo, Sergio Iannazzo, Massimo Pardini, Alessandro Squillace
Published 2019-12-01

Linked routine data to enhance health-economics analysis

by Muhammad Jami Husain, Sinead Brophy, Stefan Siebert, Ceri J. Phillips
Published 2013-03-01

Value of drug or valuable drug: a point of view issue

by Francesca Patarnello
Published 2012-12-01

Regione “Test”

by Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni
Published 2012-11-01

Precision medicine: key applications and considerations for commercial success & market access

by Morten Søgaard, Indranil Bagchi, Mikael Dolsten
Published 2014-03-01

Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model

by Mario Eandi, Lorenzo Pradelli, Massimiliano Povero
Published 2013-04-01

The use of dexmedetomidine in intensive care sedation

by Massimo Antonelli, Giorgio Conti, Andrea Belisari, Lucia S. D'Angiolella, Lorenzo Mantovani, Sabato Montella, Patrizio Piacentini, Marco Ranieri
Published 2013-05-01

A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context

by Lorenzo Pradelli, Giovanni Di Perri, Giuliano Rizzardini, Elisa Martelli, Stefano Giardina, Massimiliano Povero
Published 2017-12-01

Generic and biosimilar medicines: quid?

by Steven Simoens
Published 2012-12-01

[Kovaltry® for the replacement therapy in patients with Hemophilia A]

by Daniela Paola Roggeri, Alessio Colombo, Alessandro Roggeri
Published 2016-06-01